Thomas Hughes, Author at Newsroom

This is a temporary measure expected to last until mid-May.

Lisa A. Carey, MD, was named to the Susan G. Komen Scientific Advisory Board

As a member of Susan G. Komen’s Scientific Advisory Board, UNC Lineberger’s Lisa A. Carey, MD, will be responsible for helping guide Komen’s $956-million research program – second only to the U.S. government in funding of breast cancer research.

Compared to physicians who didn’t receive any payments, those who received payments for meals and lodging from a drug manufacturer had higher odds of prescribing that company’s particular drug for certain cancers, reported Aaron Mitchell, MD, and colleagues in JAMA Internal Medicine.

George “Rick” Stouffer, III, M.D., F.A.H.A., chief of cardiology and co-director of the McAllister Heart Institute at UNC.

The study, based on results from patients treated at UNC Hospitals, found that using genetic testing to inform which blood thinner to use following a procedure to open narrowed blood vessels resulted in significantly fewer complications. George “Rick” Stouffer, III, MD, was a leader of the study.

Study led by Seth Berkowitz, MD, MPH, assistant professor in the department of medicine, finds a 16 percent drop in emergency department and inpatient expense.

First gene therapy performed by Dr. Joseph Muenzer and the UNC Clinical Translational and Research Center.

Over the coming months, leadership from both Wake Forest Baptist and High Point Regional Health will be working together to take the necessary steps toward full integration.

UNC Lineberger's Charles M. Perou, PhD, and Lisa A. Carey, MD.

UNC Lineberger researchers Charles M. Perou, PhD, and Lisa A. Carey, MD, were part of a preclinical study led out of the Cancer Research UK Cambridge Institute that found that blocking the production of asparagine with a drug called L-asparaginase in mice with aggressive triple negative breast tumors, and putting them on a low-asparagine diet, reduced the breast tumor’s ability to spread.

Possible risks must be weighed against the benefits of supplements, a study led by Seth Crockett, MD, MPH, finds.

A team led by UNC Lineberger’s Gianpietro Dotti, MD, has engineered immune cells to hunt glioblastoma, the most lethal primary brain tumor.

UNC department chair led new guideline writing group.

Isley has served as CEO for Granville Health System in Oxford, NC, since 2006, and has held a variety of roles in his 30-year health care career.

Author Archives: Thomas Hughes

Due to Construction Project at UNC Hospitals, UNC Air Care Helicopters Are Refueling at Horace Williams Airport

Lisa Carey, international breast cancer expert, appointed to Susan G. Komen’s Scientific Advisory Board

Payments to doctors linked to prescription practices for two cancer types

Genetic test may improve post-stent treatment, outcome

Medically Tailored Meal Delivery Service Reduces Costs for High Utilizers of Health Care

UNC Pediatrics Delivers Investigational Genome Editing Therapy in Clinical Trial for the Rare Hunter Syndrome

Wake Forest Baptist, UNC Health Care Sign Binding Definitive Agreement Regarding Ownership of High Point Regional Health

To halt breast cancer’s spread, scientists block amino acid found in asparagus

Calcium supplements may increase the risk of bowel lesions

Researchers identify molecular target for brain cancer, develop immunotherapy approach to attack it

More stroke patients may receive crucial treatments under new guideline

Nash UNC Health Care Names L. Lee Isley as CEO